Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 0 | 0 | 4,793 | 0 | 0 |
| Gross Profit | N/A | N/A | 4,793 | N/A | N/A |
| Operating Expenses | 6,394 | 7,626 | 7,742 | 6,687 | 5,664 |
| Operating Income | -6,394 | -7,626 | -2,949 | -6,687 | -5,664 |
| Interest Expense | 258 | 283 | 305 | 328 | 341 |
| Other Income | -1,582 | -1,020 | -2,097 | 63 | 126 |
| Pre-tax Income | -8,234 | -8,929 | -5,351 | -6,952 | -5,879 |
| Net Income Continuous | -8,234 | -8,929 | -5,351 | -6,952 | -5,879 |
| Net Income | $-8,234 | $-8,929 | $-5,351 | $-6,952 | $-5,879 |
| EPS Basic Total Ops | -0.21 | -0.31 | -0.20 | -0.30 | -0.25 |
| EPS Basic Continuous Ops | -0.21 | -0.31 | -0.20 | -0.30 | -0.25 |
| EPS Diluted Total Ops | -0.21 | -0.31 | -0.20 | -0.30 | -0.25 |
| EPS Diluted Continuous Ops | -0.21 | -0.31 | -0.20 | -0.30 | -0.25 |
| EBITDA(a) | $-6,437 | $-7,612 | $-2,941 | $-6,682 | $-5,659 |